Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNFα-dependent manner

FASEB Journal

Volumn 24, Issue 5, 2010, Pages 1340-1346

  Noti, Mario ^a   Corazza, Nadia ^a   Tuffin, Gérald ^b   Schoonjans, Kristina ^c   Brunner, Thomas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Inflammatory bowel disease; Intestinal epithelial cells; Macrophages; TNF receptors; Tumor necrosis factor

Indexed keywords

CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CLODRONIC ACID; CYTOCHROME P450 11B1; CYTOCHROME P450 ISOENZYME; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOCORTICOID; INTERLEUKIN 6; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; TNFRSF1A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COLON; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEROIDOGENESIS; T LYMPHOCYTE; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; MOUSE MUTANT;

ANIMALIA;

ANIMALS; B-LYMPHOCYTES; GLUCOCORTICOIDS; IMMUNITY, INNATE; INTERLEUKIN-6; INTESTINES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, MUTANT STRAINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952293927     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-140913     Document Type: Article

References (42)

1. Cario, E. (2008) Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction. Curr. Opin. Gastroenterol. 24, 725-732
2. Lee, J., Gonzales-Navajas, J. M., and Raz, E. (2008) The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin. Immunopathol. 30, 3-9
3. McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H., and Radford-Smith, G. (2009) Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15, 100-113
4. Boirivant, M., Amendola, A., and Butera, A. (2008) Intestinal microflora and immunoregulation. Mucosal. Immunol. 1(Suppl. 1), S47-S49
5. Salzman, N. H., Underwood, M. A., and Bevins, C. L. (2007) Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19, 70-83
6. Muller, C. A., Autenrieth, I. B., and Peschel, A. (2005) Innate defenses of the intestinal epithelial barrier. Cell. Mol. Life Sci. 62, 1297-1307
7. Artis, D. (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8, 411-420
8. Riccardi, C., Bruscoli, S., and Migliorati, G. (2002) Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol. Res. 45, 361-368
9. Herold, M. J., McPherson, K. G., and Reichardt, H. M. (2006) Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63, 60-72
10. Schaaf, M. J., and Cidlowski, J. A. (2002) Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 83, 37-48
11. De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., and Haegeman, G. (1997) Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. U. S. A. 94, 13504-13509
12. Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., and Matsushima, K. (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269, 13289-13295 (Pubitemid 24978616)
13. Sapolsky, R. M. (2000) Stress hormones: good and bad. Neurobiol. Dis. 7, 540-542
14. Davies, E., and MacKenzie, S. M. (2003) Extra-adrenal production of corticosteroids. Clin. Exp. Pharmacol. Physiol. 30, 437-445
15. Cima, I., Corazza, N., Dick, B., Fuhrer, A., Herren, S., Jakob, S., Ayuni, E., Mueller, C., and Brunner, T. (2004) Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. J. Exp. Med. 200, 1635-1646
16. Mueller, M., Cima, I., Noti, M., Fuhrer, A., Jakob, S., Dubuquoy, L., Schoonjans, K., and Brunner, T. (2006) The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine. J. Exp. Med. 203, 2057-2062
17. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., and Alt, F. W. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867
18. Coste, A., Dubuquoy, L., Barnouin, R., Annicotte, J. S., Magnier, B., Notti, M., Corazza, N., Antal, M. C., Metzger, D., Desreumaux, P., Brunner, T., Auwerx, J., and Schoonjans, K. (2007) LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc. Natl. Acad. Sci. U. S. A. 104, 13098-13103
19. Yamada, Y., Webber, E. M., Kirillova, I., Peschon, J. J., and Fausto, N. (1998) Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28, 959-970 (Pubitemid 28450256)
20. Claassen, I., Van Rooijen, N., and Claassen, E. (1990) A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 134, 153-161
21. Van Rooijen, N. (1992) Liposome-mediated elimination of macrophages. Res. Immunol. 143, 215-219
22. Galanos, C., and Freudenberg, M. A. (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187, 346-356
23. Wilson, N. S., Dixit, V., and Ashkenazi, A. (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355
24. Chen, G., and Goeddel, D. V. (2002) TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635
25. Xu, B., Yang, W. H., Gerin, I., Hu, C. D., Hammer, G. D., and Koenig, R. J. (2009) Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol. Cell. Biol. 29, 1719-1734
26. Song, H. L., Lu, S., and Liu, P. (2005) Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure. World J. Gastroenterol. 11, 3701-3709 (Pubitemid 41149267)
27. Marini, M., Bamias, G., Rivera-Nieves, J., Moskaluk, C. A., Hoang, S. B., Ross, W. G., Pizarro, T. T., and Cominelli, F. (2003) TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100, 8366-8371
28. Gitter, A. H., Bendfeldt, K., Schulzke, J. D., and Fromm, M. (2000) Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 14, 1749-1753
29. Fries, W., Muja, C., Crisafulli, C., Costantino, G., Longo, G., Cuzzocrea, S., and Mazzon, E. (2008) Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. Int. J. Med. Sci. 5, 169-180
30. Rutgeerts, P., Vermeire, S., and Van Assche, G. (2009) Biological therapies for inflammatory bowel diseases. Gastroenterology 136, 1182-1197
31. Kassiotis, G., and Kollias, G. (2001) Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193, 427-434
32. Jacob, C. O., and McDevitt, H. O. (1988) Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 331, 356-358
33. Kontoyiannis, D., and Kollias, G. (2000) Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30, 2038-2047
34. Boivin, M. A., Ye, D., Kennedy, J. C., Al-Sadi, R., Shepela, C., and Ma, T. Y. (2007) Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G590-G598
35. Corazza, N., Eichenberger, S., Eugster, H. P., and Mueller, C. (1999) Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J. Exp. Med. 190, 1479-1492
36. Matsuguchi, T., Musikacharoen, T., Ogawa, T., and Yoshikai, Y. (2000) Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J. Immunol. 165, 5767-5772
37. Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., and Arditi, M. (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167, 1609-1616 (Pubitemid 32703162)
38. Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H. C., and Podolsky, D. K. (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966-972 (Pubitemid 30043724)
39. Otte, J. M., Cario, E., and Podolsky, D. K. (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126, 1054-1070
40. Ortega-Cava, C. F., Ishihara, S., Rumi, M. A., Kawashima, K., Ishimura, N., Kazumori, H., Udagawa, J., Kadowaki, Y., and Kinoshita, Y. (2003) Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170, 3977-3985
41. Schenk, M., and Mueller, C. (2007) Adaptations of intestinal macrophages to an antigen-rich environment. Semin. Immunol. 19, 84-93
42. Bohan, A., Chen, W. S., Denson, L. A., Held, M. A., and Boyer, J. L. (2003) Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278, 36688-36698